Over 90 per cent of physicians treating actinic keratosis (AK) prefer short duration treatment options with fast resolving local skin responses (LSRs),1 is the finding of a global study ('Physician Perceptions and Experience of Current Treatment in Actinic Keratosis') that is being presented today at the 22nd Congress of the European Academy of Dermatology and Venereology (EADV).